Activity of Isoflavans of Dalea aurea (Fabaceae) against the Opportunistic Ameba Naegleria fowleri

Abstract

One new and one known isoflavan, 3S(+)-7-methoxymanuifolin K (1) and manuifolin K (2), respectively, were isolated from methanolic extracts of Dalea aurea (Fabaceae). Isoflavans 1 and 2 exhibited significant in vitro activity against the ameba Naegleria fowleri, an organism responsible for an infrequent but rapidly fatal form of primary amebic meningoencephalitis (PAM). At concentrations of 30 μM, both 1 and 2 caused growth inhibition of N. fowleri at a level comparable to amphotericin B (at 0.1 μM), the currently preferred treatment for this disease. Over a seven-day growth period, 1 and 2 (30 μM) exhibited superior growth inhibition of N. fowleri than amphotericin B after day 4. Isoflavan 2 was evaluated in a mouse model of PAM at a dose of 25 mg/kg/day for five days. While amphotericin B (2.5 mg/kg/day) offered 12.5 % protection of the mice, compound 2 did not protect the mice from PAM infection compared to controls.

References

• 1 Belofsky G, French A N, Wallace D R, Dodson S R. New geranyl stilbenes from Dalea purpurea with in vitro opioid receptor affinity.  J Nat Prod. 2004;  67 26-30
• 2 Belofsky G, Percivill D, Lewis K, Tegos G P, Ekart J. Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria.  J Nat Prod. 2004;  67 481-4
• 3 Hufford C D, Jia Y, Croom E M, Muhammed I, Okunade A L, Clark A M. Antimicrobial compounds from Petalostemum purpureum .  J Nat Prod. 1993;  56 1878-89
• 4 Moerman D E. Native American ethnobotany. Portland; Timber Press Inc 1998: p 192
• 5 John D T. In: Kreier JP, Baker JR, editors Parasitic protozoa. 2nd edition, Vol. 3 San Diego; Academic Press Inc 1993: p 143-246
• 6 Apley J S, Clarke S K, Roome A P, Sandry S A, Saygi G, Silk B. et al . Primary amebic meningoencephalitis in Britain.  Br Med J. 1970;  1 596-9
• 7 Wang A, Kay R, Poon W S, Ng H K. Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong.  Clin Neurol Neurosurg. 1993;  95 249-52
• 8 Stevens A R, Shulman S T, Lansen T A, Cichon M J, Willaert E. Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies.  J Infect Dis. 1981;  143 193-9
• 9 Goswick S M, Brenner G M. Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.  Antimicrob Agents Chemother. 2003;  47 524-8
• 10 Goswick S M, Brenner G M. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.  J Parasitol. 2003;  89 837-42
• 11 Zeng J F, Wei H X, Li G L, Zhu D Y. Three prenylated isoflavans from Maackia tenuifolia .  Phytochemistry. 1998;  47 903-5
• 12 Jha H C, Zilliken F, Breitmaier E. Carbon-13 chemical shift assignments of chromones and isoflavones.  Can J Chem. 1980;  58 1211-9
• 13 Rama Murthy M S, Rao E V, Ward R S. Carbon-13 nuclear magnetic resonance spectra of isoflavones.  Magn Reson Chem. 1986;  24 225-30
• 14 Versteeg M, Bezuidenhoudt B CB, Ferreira D. Stereoselective synthesis of isoflavanoids. (R)- and (S)-isoflavans.  Tetrahedron. 1999;  55 3365-76
• 15 Martinez A J, Nelson E C, Duma R J. Animal model: primary amebic (Naegleria) meningoencephalitis in mice.  Am J Pathol. 1973;  73 545-8
• 16 John D T, Weik R R, Adams A C. Immunization of mice against Naegleria fowleri infection.  Infect Immun. 1977;  16 817-20